RINAT NEUROSCIENCE CORP.
Patent Owner
Stats
- 37 US PATENTS IN FORCE
- 4 US APPLICATIONS PENDING
- Feb 15, 2018 most recent publication
Details
- 37 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 2,357 Total Citation Count
- Oct 06, 2003 Earliest Filing
- 21 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0313,787 ENGINEERED POLYPEPTIDE CONJUGATES AND METHODS FOR MAKING THEREOF USING TRANSGLUTAMINASEMay 11, 17Nov 02, 17[C07K]
2015/0269,312 SYSTEMS AND METHODS OF SENSING AND ANALYZING ANTIBODY BLOCKING INTERACTIONSDec 02, 14Sep 24, 15[G01N, G06F]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9676871 Engineered polypeptide conjugates and methods for making thereof using transglutaminaseNov 03, 11Jun 13, 17[A61K, C07K]
9527926 Heterodimeric proteins and methods for producing and purifying themMay 13, 11Dec 27, 16[A61K, C07K]
9498530 Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the sameJul 19, 13Nov 22, 16[A61K, C07K]
9346885 Method of treating type 1 diabetes with antagonist IL-7 receptor antibodiesDec 17, 13May 24, 16[A61K, C07K]
9340610 Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the sameJul 19, 13May 17, 16[A61K, C07K]
9249224 Human growth hormone receptor antagonist antibodies and methods of use thereofDec 10, 12Feb 02, 16[A61K, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2013/0236,451 ANTIBODIES DIRECTED AGAINST AMYLOID-BETA PEPTIDE AND METHODS USING SAMEAbandonedFeb 14, 13Sep 12, 13[C07K]
2011/0281,348 AGONIST ANTI-TRKC ANTIBODIES AND METHODS USING SAMEAbandonedMay 13, 11Nov 17, 11[C12N, C07K]
7935342 Methods for treating obesity by administering a trkB antagonistExpiredJan 29, 07May 03, 11[A61K]
2011/0038,861 Methods of Treating Alzheimer's Disease Using Antibodies Directed Against Amyloid Beta Peptide and Compositions ThereofAbandonedJun 30, 10Feb 17, 11[A61K, A61P]
2010/0196,390 AGONIST ANTI-TRKB MONOCLONAL ANTIBODIESAbandonedFeb 01, 10Aug 05, 10[A61K, C12N, A61P, C07K]
7655231 Methods for treating pain by administering a nerve growth factor antagonist and an NSAIDExpiredFeb 19, 04Feb 02, 10[A61K, C12P, C07K]
2009/0291,897 METHODS FOR TREATING UNWANTED WEIGHT LOSS OR EATING DISORDERS BY ADMINISTERING A TRKB AGONISTAbandonedJul 23, 09Nov 26, 09[A61K, A61P]
2009/0203,610 METHODS OF TREATING OBESITY OR DIABETES USING NT-4/5AbandonedMar 13, 09Aug 13, 09[A61K]
2007/0275,374 Methods For Idendifying Drug Targets And Modulators Of Neurons and Compositions Comprising The SameAbandonedMar 17, 04Nov 29, 07[C12Q, C12M, G01N]
2007/0160,616 Methods of treating Alzheimer's disease using antibodies directed against amyloid beta peptide and compositions thereofAbandonedJan 12, 07Jul 12, 07[A61K]
2007/0031,418 Methods for treating lower motor neuron diseases and compositions containing the sameAbandonedApr 26, 06Feb 08, 07[A61K]
2006/0147,450 Methods for treating cardiac arrhythmia and preventing death due to cardiac arrhythmia using ngf antagonistsAbandonedOct 06, 03Jul 06, 06[A61K]
2006/0147,932 Methods of screening for modulators of nerve growth factorAbandonedJan 20, 04Jul 06, 06[C12Q, G01N]
2005/0089,521 Methods for treating taxol-induced sensory neuropathyAbandonedDec 23, 03Apr 28, 05[A61K]
2004/0146,512 Methods of treating Alzheimer's disease using antibodies directed against amyloid beta peptide and compositions thereofAbandonedOct 09, 03Jul 29, 04[A61K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
